At least 47,677 global drug marketing authorizations could be affected and over 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances in Europe is implemented, warned the European Federation of Pharmaceutical Industries Associations.
Europe’s Proposed Chemical Ban Could Hit Many Thousands Of Global Marketing Authorizations
Drug manufacturing in the EU would grind to a halt in under three years if a proposal to restrict per- and polyfluoroalkyl substances in the European Economic Area is implemented in its current form, says industry group EFPIA.
